期刊文献+

Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia 被引量:2

Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia
原文传递
导出
摘要 Background Implantable cardioverter defibrillator (ICD) is the only effective therapy in patients with life threatening ventricular arrhythmias. Inappropriate detection and therapy by ICDs are the most common causes of side effects that affect the quality of life in ICD recipients. This study evaluated the incidence and causes of inappropriate detection and therapy by ICDs in patients in our hospital. Methods From January 2000 to December 2005, fifty patients who received ICD implantation for ventricular arrhythmias for prevention of sudden cardiac death were evaluated in this study. Each ICD was programmed using clinical arrhythmic and cardiac data of the patient before discharge. Patients were followed up by standard schedule after implantation and all data retrieved from each device were collected and saved for further analysis. Results No arrhythmic event was detected in 12/50 (24%) patients during the period of follow-up. Among the remaining patients, 11 (22%) experienced inappropriate detections and therapies during follow-up in this study. ICD detected 383 ventricular tachyarrhythmia (VT) and 108 ventricular fibrillation (VF) episodes and delivered 678 therapies. In VT group, ICD delivered 413 antitachycardiac pacings (ATPs) and 118 shocks, among which 78 ATPs and 9 shocks were initiated by 55/383 (14.3%) inappropriate detections. In VF group ICD delivered 147 shocks, among which 56 shocks were initiated by 28/108 (26.9%) inappropriate detections. Overall, more than 50% of these episodes were caused by atrial fibrillation (AF) with rapid ventricular response, followed by electromagnetic or myopotential interference. In addition, most inappropriate therapies occurred within one year after ICD implantation. Conclusions About one fifth of patients experienced ICD inappropriate detection and therapy after implantation. The main cause was AF with rapid ventricular response, followed by electromagnetic or myopotential interference. Background Implantable cardioverter defibrillator (ICD) is the only effective therapy in patients with life threatening ventricular arrhythmias. Inappropriate detection and therapy by ICDs are the most common causes of side effects that affect the quality of life in ICD recipients. This study evaluated the incidence and causes of inappropriate detection and therapy by ICDs in patients in our hospital. Methods From January 2000 to December 2005, fifty patients who received ICD implantation for ventricular arrhythmias for prevention of sudden cardiac death were evaluated in this study. Each ICD was programmed using clinical arrhythmic and cardiac data of the patient before discharge. Patients were followed up by standard schedule after implantation and all data retrieved from each device were collected and saved for further analysis. Results No arrhythmic event was detected in 12/50 (24%) patients during the period of follow-up. Among the remaining patients, 11 (22%) experienced inappropriate detections and therapies during follow-up in this study. ICD detected 383 ventricular tachyarrhythmia (VT) and 108 ventricular fibrillation (VF) episodes and delivered 678 therapies. In VT group, ICD delivered 413 antitachycardiac pacings (ATPs) and 118 shocks, among which 78 ATPs and 9 shocks were initiated by 55/383 (14.3%) inappropriate detections. In VF group ICD delivered 147 shocks, among which 56 shocks were initiated by 28/108 (26.9%) inappropriate detections. Overall, more than 50% of these episodes were caused by atrial fibrillation (AF) with rapid ventricular response, followed by electromagnetic or myopotential interference. In addition, most inappropriate therapies occurred within one year after ICD implantation. Conclusions About one fifth of patients experienced ICD inappropriate detection and therapy after implantation. The main cause was AF with rapid ventricular response, followed by electromagnetic or myopotential interference.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2006年第7期557-563,共7页 中华医学杂志(英文版)
关键词 CARDIOVERSION inappropriate detection inappropnate therapy implantable cardioverter defibrillator ventricular tachyarrhythmia cardioversion inappropriate detection inappropnate therapy implantable cardioverter defibrillator ventricular tachyarrhythmia
  • 相关文献

参考文献12

  • 1Ulrika Birgersdotter Green,Ashok Garg,Fawzia Al-Kandari,GilAnthony Ungab,Linda Tone,Gregory K. Feld.Successful Implantation of Cardiac Defibrillators Without Induction of Ventricular Fibrillation Using Upper Limit of Vulnerability Testing[J].Journal of Interventional Cardiac Electrophysiology.2003(1)
  • 2T. Korte,H. J. Trappe,G. Gr?nefeld,B. Schulte,C. Wolpert,M. Meesmann,D. B?cker,D. Gro?e Meininghaus,J. Vogt,C. Stellbrink.Neues ICD-Morphologie-Kriterium zur Differenzierung supraventrikul?rer und ventrikul?rer Tachykardien[J].Zeitschrift für Kardiologie.2000(11)
  • 3Kuhlkamp V,Dornberger V,Mewis C,Suchalla R,Bosch RF,Seipel L.Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing[].Journal of Cardiovascular Electrophysiology.1999
  • 4Olson WH,Bardy GH,Mehra R.Onset and stability of ventricular tachyarrhythmia detection in an implantable pacer-cardioverter-defibrillator[].Computers in Cardiology.1987
  • 5Buxton AE,Lee KL,Fisher JD,Josephson ME,Prystowsky EN,Hafley G.A randomized study of the prevention of sudden cardiac death in patients with coronary artery disease[].The New England Journal of Medicine.1999
  • 6Nunain SO,Roelke M,Trouton T,Osswald S,Kim YH,Sosa-Suarez G,et al.Limitations and late complications of third generation automatic cardioverter-defibrillators[].Circulation.1995
  • 7Weber M,Block M,Brunn J,Bansch D,Bocker D,Hammel D,et al.Inappropriate ICD-therapies: Incidence, causes, risk factors and prevention[].Zeitschrift fur Kardiologie.1996
  • 8Schoels W,Swerdlow CD,Jung W,Stein KM,Seidl K,Haffajee CJ,et al.Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system[].Journal of Cardiovascular Electrophysiology.2001
  • 9Lavergne T,Daubert JC,Chauvin M,Dolla E,Kacet S,Leenhardt A,et al.Preliminary clinical experience with the first dual chamber pacemaker defibrillator[].Pacing and Clinical Electrophysiology.1997
  • 10Deisenhofer I,Kolb C,Ndrepepa G,Schreieck J,Karch M,Schmieder S,et al.Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study[].Journal of Cardiovascular Electrophysiology.2001

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部